{
"info": {
"nct_id": "NCT00475657",
"official_title": "Phase II Study of Pemetrexed Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung Cancer",
"inclusion_criteria": "* Histologic or cytologic diagnosis of Small Cell Lung Cancer (SCLC).\n* Functional stage from 0 to 2 of the ECOG functional scale\n* No previous systemic chemotherapy, immunotherapy or biologic therapy for SCLC.\n* Previous bone marrow radiotherapy less than 25% is allowed.\n* There must be at least one measurable lesion that complies with the solid tumor response evaluation criteria.\n* Appropriate organic function.\n* Life expectancy estimated at 12 weeks minimum.\n* Females must be surgically sterile, postmenopausal or follow approved medical contraceptive methods during the treatment period and 6 months afterwards. Males must be surgically sterile or use a contraceptive method during the treatment period and during 6 months after treatment.\n* The patient must be compliant and located close to the trial area for appropriate follow-up.\n* The patient or his/her legal representative must sign an informed consent document.\n* Patients must be at least 18 years of age.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Having received treatment for the last 30 days with a drug that has not obtained regulatory approval.\n* Having participated in a previous pemetrexed trial.\n* Mixed histologic diagnosis of SCLC and NSCLC.\n* Concurrent illness.\n* Having an active infection.\n* Severe cardiac disease.\n* Having received recently or concurrently a vaccine against yellow fever.\n* Having suffered a previous malignant process other than SCLC.\n* Central nervous system (CNS) metastases require concurrent corticoid therapy. Treated and stable CNS metastases are allowed.\n* Clinically relevant fluid accumulation in the third space.\n* Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion.\n* Concurrent administration of any other anti-tumor treatment.\n* Severe renal failure.\n* Unable to discontinue administration of non-steroidal anti-inflammatory (NSAIDS) agents.\n* Inability or unwillingness to take folic acid and vitamin B12 supplements.\n* Inability to take corticoids.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologic or cytologic diagnosis of Small Cell Lung Cancer (SCLC).",
"criterions": [
{
"exact_snippets": "Histologic or cytologic diagnosis of Small Cell Lung Cancer (SCLC)",
"criterion": "Small Cell Lung Cancer (SCLC)",
"requirements": [
{
"requirement_type": "diagnosis method",
"expected_value": [
"histologic",
"cytologic"
]
}
]
}
]
},
{
"line": "* Functional stage from 0 to 2 of the ECOG functional scale",
"criterions": [
{
"exact_snippets": "Functional stage from 0 to 2 of the ECOG functional scale",
"criterion": "ECOG functional scale",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* No previous systemic chemotherapy, immunotherapy or biologic therapy for SCLC.",
"criterions": [
{
"exact_snippets": "No previous systemic chemotherapy",
"criterion": "previous systemic chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No previous ... immunotherapy",
"criterion": "previous immunotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No previous ... biologic therapy",
"criterion": "previous biologic therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Previous bone marrow radiotherapy less than 25% is allowed.",
"criterions": [
{
"exact_snippets": "Previous bone marrow radiotherapy less than 25% is allowed.",
"criterion": "bone marrow radiotherapy",
"requirements": [
{
"requirement_type": "extent",
"expected_value": {
"operator": "<",
"value": 25,
"unit": "%"
}
}
]
}
]
},
{
"line": "* There must be at least one measurable lesion that complies with the solid tumor response evaluation criteria.",
"criterions": [
{
"exact_snippets": "at least one measurable lesion",
"criterion": "measurable lesion",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "complies with the solid tumor response evaluation criteria",
"criterion": "compliance with solid tumor response evaluation criteria",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": true
}
]
}
]
},
{
"line": "* Appropriate organic function.",
"criterions": [
{
"exact_snippets": "Appropriate organic function.",
"criterion": "organic function",
"requirements": [
{
"requirement_type": "appropriateness",
"expected_value": true
}
]
}
]
},
{
"line": "* Life expectancy estimated at 12 weeks minimum.",
"criterions": [
{
"exact_snippets": "Life expectancy estimated at 12 weeks minimum.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Females must be surgically sterile, postmenopausal or follow approved medical contraceptive methods during the treatment period and 6 months afterwards. Males must be surgically sterile or use a contraceptive method during the treatment period and during 6 months after treatment.",
"criterions": [
{
"exact_snippets": "Females must be surgically sterile",
"criterion": "female surgical sterility",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Females must be ... postmenopausal",
"criterion": "female postmenopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "postmenopausal"
}
]
},
{
"exact_snippets": "Females must ... follow approved medical contraceptive methods during the treatment period and 6 months afterwards",
"criterion": "female contraceptive use",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "during the treatment period and 6 months afterwards"
}
]
},
{
"exact_snippets": "Males must be surgically sterile",
"criterion": "male surgical sterility",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Males must ... use a contraceptive method during the treatment period and during 6 months after treatment",
"criterion": "male contraceptive use",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "during the treatment period and during 6 months after treatment"
}
]
}
]
},
{
"line": "* The patient must be compliant and located close to the trial area for appropriate follow-up.",
"criterions": [
{
"exact_snippets": "The patient must be compliant",
"criterion": "compliance",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "located close to the trial area",
"criterion": "location",
"requirements": [
{
"requirement_type": "proximity",
"expected_value": "close to the trial area"
}
]
}
]
},
{
"line": "* The patient or his/her legal representative must sign an informed consent document.",
"criterions": [
{
"exact_snippets": "The patient or his/her legal representative must sign an informed consent document.",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients must be at least 18 years of age.",
"criterions": [
{
"exact_snippets": "Patients must be at least 18 years of age.",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Having received treatment for the last 30 days with a drug that has not obtained regulatory approval.",
"criterions": [
{
"exact_snippets": "received treatment for the last 30 days",
"criterion": "treatment duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "=",
"value": 30,
"unit": "days"
}
}
]
},
{
"exact_snippets": "drug that has not obtained regulatory approval",
"criterion": "drug approval status",
"requirements": [
{
"requirement_type": "approval status",
"expected_value": "not obtained"
}
]
}
]
},
{
"line": "* Having participated in a previous pemetrexed trial.",
"criterions": [
{
"exact_snippets": "Having participated in a previous pemetrexed trial",
"criterion": "previous pemetrexed trial participation",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
},
{
"line": "* Mixed histologic diagnosis of SCLC and NSCLC.",
"criterions": [
{
"exact_snippets": "Mixed histologic diagnosis of SCLC and NSCLC.",
"criterion": "histologic diagnosis",
"requirements": [
{
"requirement_type": "types",
"expected_value": [
"SCLC",
"NSCLC"
]
}
]
}
]
},
{
"line": "* Concurrent illness.",
"criterions": [
{
"exact_snippets": "Concurrent illness.",
"criterion": "concurrent illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Having an active infection.",
"criterions": [
{
"exact_snippets": "Having an active infection",
"criterion": "active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Severe cardiac disease.",
"criterions": [
{
"exact_snippets": "Severe cardiac disease.",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
}
]
},
{
"line": "* Having received recently or concurrently a vaccine against yellow fever.",
"criterions": [
{
"exact_snippets": "received recently or concurrently a vaccine against yellow fever",
"criterion": "yellow fever vaccine",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "recently or concurrently"
}
]
}
]
},
{
"line": "* Having suffered a previous malignant process other than SCLC.",
"criterions": [
{
"exact_snippets": "suffered a previous malignant process other than SCLC",
"criterion": "previous malignant process",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "type",
"expected_value": "other than SCLC"
}
]
}
]
},
{
"line": "* Central nervous system (CNS) metastases require concurrent corticoid therapy. Treated and stable CNS metastases are allowed.",
"criterions": [
{
"exact_snippets": "Central nervous system (CNS) metastases require concurrent corticoid therapy.",
"criterion": "CNS metastases",
"requirements": [
{
"requirement_type": "concurrent corticoid therapy",
"expected_value": true
}
]
},
{
"exact_snippets": "Treated and stable CNS metastases are allowed.",
"criterion": "CNS metastases",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "treated"
},
{
"requirement_type": "stability",
"expected_value": "stable"
}
]
}
]
},
{
"line": "* Clinically relevant fluid accumulation in the third space.",
"criterions": [
{
"exact_snippets": "Clinically relevant fluid accumulation in the third space.",
"criterion": "fluid accumulation",
"requirements": [
{
"requirement_type": "location",
"expected_value": "third space"
},
{
"requirement_type": "clinical relevance",
"expected_value": true
}
]
}
]
},
{
"line": "* Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion.",
"criterions": [
{
"exact_snippets": "Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion.",
"criterion": "weight loss",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "%"
}
},
{
"requirement_type": "time frame",
"expected_value": "within 6 weeks prior to trial inclusion"
}
]
}
]
},
{
"line": "* Concurrent administration of any other anti-tumor treatment.",
"criterions": [
{
"exact_snippets": "Concurrent administration of any other anti-tumor treatment.",
"criterion": "concurrent anti-tumor treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Severe renal failure.",
"criterions": [
{
"exact_snippets": "Severe renal failure",
"criterion": "renal failure",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
}
]
},
{
"line": "* Unable to discontinue administration of non-steroidal anti-inflammatory (NSAIDS) agents.",
"criterions": [
{
"exact_snippets": "Unable to discontinue administration of non-steroidal anti-inflammatory (NSAIDS) agents.",
"criterion": "discontinuation of NSAIDS",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
},
{
"line": "* Inability or unwillingness to take folic acid and vitamin B12 supplements.",
"criterions": [
{
"exact_snippets": "Inability or unwillingness to take folic acid",
"criterion": "folic acid supplementation",
"requirements": [
{
"requirement_type": "ability or willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "Inability or unwillingness to take ... vitamin B12 supplements",
"criterion": "vitamin B12 supplementation",
"requirements": [
{
"requirement_type": "ability or willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* Inability to take corticoids.",
"criterions": [
{
"exact_snippets": "Inability to take corticoids",
"criterion": "corticoid intake ability",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}